Point-of-Care or Rapid Diagnostics Device Market

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Point-of-Care or Rapid Diagnostics Device Market contains market size and forecasts of Point-of-Care or Rapid Diagnostics Device in global, including the following market information:
Global Point-of-Care or Rapid Diagnostics Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Point-of-Care or Rapid Diagnostics Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Point-of-Care or Rapid Diagnostics Device companies in 2021 (%)
The global Point-of-Care or Rapid Diagnostics Device market was valued at 26410 million in 2021 and is projected to reach US$ 47710 million by 2028, at a CAGR of 8.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Glucose Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point-of-Care or Rapid Diagnostics Device include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Sinocare, Wondfo and Yuwell, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Point-of-Care or Rapid Diagnostics Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point-of-Care or Rapid Diagnostics Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point-of-Care or Rapid Diagnostics Device Market Segment Percentages, by Type, 2021 (%)
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
Global Point-of-Care or Rapid Diagnostics Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point-of-Care or Rapid Diagnostics Device Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Laboratory
Others
Global Point-of-Care or Rapid Diagnostics Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point-of-Care or Rapid Diagnostics Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point-of-Care or Rapid Diagnostics Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Point-of-Care or Rapid Diagnostics Device revenues share in global market, 2021 (%)
Key companies Point-of-Care or Rapid Diagnostics Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Point-of-Care or Rapid Diagnostics Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan EasyDiagnosis Biomedicine
DAAN GENE